Legal Representation
Attorney
Tara Reedy Sliva
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 8, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 8, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 22, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 22, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 22, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 21, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 15, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 18, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Synthetic resins for use in combinatorial, peptide and organic chemistry; Reagents for scientific and research use; Chemical and biochemical preparations, namely, reagents for peptide synthesis; Resins for use in solidphase peptide synthesis for scientific diagnostic use; Biochemicals and organic chemicals used as enzyme substrates, enzyme inducers, namely, aminoglutethimides, carbamazepines, griseofulvins, and primidones, enzyme inactivators, or cultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposes, namely, for use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Classification
International Classes
001